MedPath

To evaluate the effectiveness of Haridradi lepa in management of Mukhdushika (Acne vulgaris)

Phase 2
Conditions
Health Condition 1: L700- Acne vulgaris
Registration Number
CTRI/2024/05/067018
Lead Sponsor
Dr Priyanka Yadav
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients having sign and symptoms of mukhdushika

Age between 13 years to 50 years

Exclusion Criteria

Patients having known case of Eczema , Urticaria, Impetigo, Contact Dermatitis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the efficacy of Haridradi lepa in reduction of mukhdushika using CASS ScaleTimepoint: 07 days
Secondary Outcome Measures
NameTimeMethod
To assess the efficacy of Haridradi lepa in reduction of vedana(pain), vivarnta(discolouration), number of pidika by using subjective parameters.Timepoint: 07 days
© Copyright 2025. All Rights Reserved by MedPath